Literature DB >> 8122123

Central analgesic activity of nonsteroidal antiinflammatory drugs in animal and human pain models.

E Urquhart1.   

Abstract

Nonsteroidal antiinflammatory drugs (NSAIDs) often are considered peripherally acting analgesics. This traditional view has been challenged by several authors who have put forward evidence for a central analgesic action for both acidic and nonacidic NSAIDs. The most compelling evidence, reviewed in this report, comes from well-defined animal pain models in which central administration of low doses of NSAIDs provides effective analgesia. In humans, the nociceptive flexion reflex provides a valuable means of dissociating central and peripheral effects. The mechanism of the central action of NSAIDs remains unclear. Several lines of evidence implicate the inhibition of central prostaglandin synthesis, particularly in models with a strong hyperalgesic component to their pathophysiology. However, not all potent inhibitors of prostaglandin synthesis are active by central routes of administration, and it seems likely that other actions may be involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8122123     DOI: 10.1016/s0049-0172(05)80041-1

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  3 in total

Review 1.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Comparative study of analgesic efficacy and morphine-sparing effect of intramuscular dexketoprofen trometamol with ketoprofen or placebo after major orthopaedic surgery.

Authors:  M H Hanna; K M Elliott; M E Stuart-Taylor; D R Roberts; D Buggy; G J Arthurs
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

Review 3.  Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.

Authors:  C R Lee; J A Balfour
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.